OBIO CAAP Company, TECLA, features Switch Control and Platform Switching as an essential part of independence at home.

Pathcore won 1st Place at RESI Innovation Challenge in San Francisco!

An Executive Team from Taiwanese multinational, Wistron, will be visiting Canada with stops in Toronto, Ottawa and Montreal during the week of Feb 13, 2017 (Feb 13-14 in Toronto). Wistron is seeking partnerships including JVs, equity investments and distribution in sectors of medical technology, artificial intelligence, machine learning and Big Data.

You are invited to participate in this year’s biggest Ontario-China collaboration event in Toronto. Registration is free!

The Ministry of Research, Innovation and Science in partnership with the Consulate General of China in Toronto will host the 6th Ontario-China Research and Innovation Collaboration Forum (May 15) in conjunction with the 2017 OCE Discovery event to further strengthen collaboration under the Ontario-China MOU on Research and Innovation signed between the Government of Ontario and the Ministry of Science and Technology of China.

China is investing significantly in innovation to drive the economic growth. This provides golden opportunities for all of Ontario’s technology sectors. We look forward to your participation and engagement. 

The Honourable Minister Reza Moridi of the Ministry of Research, Innovation and Science and the Consul General from the Consulate General of China, have been invited to participate in the event and provide opening remarks at the Forum.

OBIO Pre-CAAP company Winterlight Labs has been featured in WIRED alongside cutting-edge tech for detecting autism and genetic disorders.

The Health Innovation Hub is Springboard’s program for women-led companies seeking growth funding and expert connections to develop solutions in pharma, including new drugs, diagnostics, pharma technologies, and drug-delivery devices.

TORONTO, CANADA -- (January 5, 2017) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced it has secured CDN $21.5 million in a Series C investment to commercialize its ExactVu™ micro-ultrasound system.

TORONTO & MONTREAL & VANCOUVER, British Columbia December 19, 2016 -Versant Ventures today announced that Toronto-based portfolio company Northern Biologics Inc. has executed a transformational deal that expands its pipeline and financial resources, bringing commitments to Versant’s Canadian biotech portfolio to over CAD$500 million.

Proteocyte Diagnostics Inc. announced new support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) for their novel prognostic oral cancer laboratory service.

Vancouver and Toronto, Canada (November 3, 2016) — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, announced it has received a $525,000 investment from Canadian partners: Accel-Rx Health Sciences Accelerator, The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI).

TORONTO and NEW YORK (November 3, 2016) — Synaptive Medical, a leading medical device and technology company that pursues connections to transform the process of care, announced today that General Atlantic, a global growth equity firm, has made a strategic investment in the company. With over 35 years of experience investing in 250 growth companies and deep expertise in the healthcare and technology sectors, General Atlantic partners with entrepreneurs and management teams around the world to help them accelerate growth and become market leaders.

IT’S A START is an exciting and interactive pitch competition taking place at Digifest 2017. Pitch your business, convince expert judges of its value, and wow the crowd in 5 minutes, and you will have the chance to meet with investors, win thousands in cash, incubation space, and mentorship.